Glofitamab Plus R-Chop Or Polatuzumab Vedotin-R-Chp Is Deliverable And Yields High Overall Response In Patients <=65 Years Of Age With High-Risk Dlbcl Or Hgbl: Interim Analysis Of The Coalition Study
Glofitamab;Polatuzumab Vedotin;R-CHOP
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Glofitamab Plus R-Chop Or Polatuzumab Vedotin-R-Chp Is Deliverable And Yields High Overall Response In Patients <=65 Years Of Age With High-Risk Dlbcl Or Hgbl: Interim Analysis Of The Coalition Study ### Output: Glofitamab;Polatuzumab Vedotin;R-CHOP